Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, November 29, 2014
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Gene Therapy Provides Safe, Long-Term Relief for Patients with Severe Hemophilia B
Gene therapy pioneered by St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital provides men with hemophilia B reliable relief from the bleeding disorder.
Protein Predicts Response To New Immunotherapy Drug
Trial shows that response to treatment may be predicted by the presence of an immune-suppressing protein in non-cancerous immune cells.
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response
Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine.
Researchers Develop Efficient Method to Produce Nanoporous Metals
New technique to manufacture nanoporous metals is cheap and can be done over many scales.
Turkeys may be Lifesavers
Antibiotic to target staph infections, strep, comes from good bacteria in turkeys.
A Hybrid Vehicle That Delivers DNA
University at Buffalo researchers are developing new technology to improve DNA vaccines. The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.
Big Data Set To Make A Big Difference In Childhood Cancer Treatment
UTS researchers are working with the Kids Research Institute to visualise large quantities of patient data to better diagnose and treat childhood cancer patients.
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
A Link between DNA Transcription and Disease-Causing Expansions Which Lead to Hereditary Disorders
A Tufts University study explores the relationship between transcription and the expansions of DNA repeats.
Did You Hear The One About The Two Businessmen On A Plane?
EquipNet’s vision ‘to revolutionize the way companies manage their surplus assets’ was first conceived at 30,000 feet somewhere between Chicago and Boston in 1999. Here we learn more about the company's first 15 years.
Scroll Up
Scroll Down
Return
Continuous Chromatography (MCSGP) for the Purification of Therapeutic Proteins
Dr Thomas Müller-Späth, ETH Switzerland, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Date Posted: Saturday, June 16, 2012
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Controlling Genes with Your Thoughts
Researchers develop the first gene network to be operated via brainwaves.
Tuesday, November 11, 2014
New Defence Mechanism Against Viruses Discovered
Mechanism may represent one of the oldest defence mechanisms against viruses in evolutionary history.
Friday, September 12, 2014
Protecting Olive Oil from Counterfeiters
Using magnetic DNA particles, ETH Zurich researchers have shown how olive oil can be tagged to prevent counterfeiting.
Friday, April 25, 2014
New African Cassava Resists Devastating Viruses
Plant scientists at ETH Zurich have developed a new African cassava preferred by consumers and farmers that is resistant to the two major virus diseases in Africa. Now they want to test the resistant cassava in Africa.
Tuesday, October 02, 2012
Swiss researchers develop rice with increased (six-fold!) iron content
Scientists at ETH Zurich have developed rice plants that contain six times more iron in polished rice kernels.
Thursday, August 20, 2009
 

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv